Doximity vs M3 Inc
M3 holds the stronger position because its core doctor network faces low competitive pressure and is unlikely to be replaced by AI, while Doximity's growth is slowing as OpenEvidence pulls clinician attention away.
Doximity
Doximity runs the verified network and workflow tools most US doctors use daily
M3 Inc
M3 Inc runs Japan's largest physician network platform, m3.com, linking doctors, pharma, and health data
Dimension by dimension
| Dimension | Doximity | M3 Inc |
|---|---|---|
| Staying power of the core product | Doximity is described as losing its protection despite still being the network most US doctors use daily. | M3 is described as built to last, running Japan's largest verified doctor network with no visible customer loss. |
| Exposure to AI absorbing the product | AI is partly absorbing what Doximity offers, especially through AI tools clinicians now use instead. | AI is unlikely to absorb what M3 offers. |
| How easily a giant could copy them | A giant copying Doximity's network is also considered blocked. | A giant copying M3's network is considered blocked. |
| Pressure from rivals | Doximity faces heavier direct pressure than M3, with OpenEvidence actively pulling clinician attention and usage away, backed by Epic ties and over 860,000 clinicians, assessed July 2026. | M3 faces only JFTC scrutiny and distant rivals like Doximity and DXY to watch, assessed July 2026. |
| Revenue growth trajectory | Doximity's revenue grew 13% in FY2026 but guidance for FY2027 points to only about 4% growth. | M3's revenue grew 23.3% year over year with operating profit up 16.8%. |
| Cash generation | Doximity's free cash flow rose 19% to $317.5 million, showing strong cash conversion despite slowing revenue growth. | No free cash flow figure is given for M3 in the evidence provided. |
| Overall competitive strength | Doximity combines a leading US clinician network with over 860,000 users, but slowing revenue growth guidance and rising pressure from OpenEvidence, assessed July 2026. | M3 combines Japan's largest verified doctor network, 23.3% revenue growth, and low direct rival pressure, assessed July 2026. |
Questions people ask
- M3 vs Doximity which is safer from AI disruption
- M3 is marked as unlikely to be absorbed by AI, while Doximity is marked as partly exposed. That gap is the clearest difference between the two companies right now.
- Which company is growing faster, M3 or Doximity
- M3 grew revenue 23.3% year over year with operating profit up 16.8%. Doximity grew revenue 13% but its own guidance points to growth slowing to around 4% next year.
- Can Google or Microsoft just build what M3 or Doximity built
- Both are marked as blocked from being easily copied by a giant. Neither company's evidence shows this as a point of difference.
- Does Doximity have better cash flow than M3
- The evidence only shows a free cash flow figure for Doximity, which rose 19% to $317.5 million. No comparable figure is given for M3, so a direct comparison on this point cannot be made.